3kpm › Citations

T cell allorecognition via molecular mimicry.

Macdonald WA, Chen Z, Gras S, Archbold JK, Tynan FE, Clements CS, Bharadwaj M, Kjer-Nielsen L, Saunders PM, Wilce MC, Crawford F, Stadinsky B, Jackson D, Brooks AG, Purcell AW, Kappler JW, Burrows SR, Rossjohn J, McCluskey J
Immunity 31 897-908 (2009)
Related entries: 3kpl, 3kpn, 3kpo, 3kpp, 3kpq, 3kpr, 3kps

Cited: 174 times
EuropePMC logo PMID: 20064448

Abstract

T cells often alloreact with foreign human leukocyte antigens (HLA). Here we showed the LC13 T cell receptor (TCR), selected for recognition on self-HLA-B( *)0801 bound to a viral peptide, alloreacts with B44 allotypes (HLA-B( *)4402 and HLA-B( *)4405) bound to two different allopeptides. Despite extensive polymorphism between HLA-B( *)0801, HLA-B( *)4402, and HLA-B( *)4405 and the disparate sequences of the viral and allopeptides, the LC13 TCR engaged these peptide-HLA (pHLA) complexes identically, accommodating mimicry of the viral peptide by the allopeptide. The viral and allopeptides adopted similar conformations only after TCR ligation, revealing an induced-fit mechanism of molecular mimicry. The LC13 T cells did not alloreact against HLA-B( *)4403, and the single residue polymorphism between HLA-B( *)4402 and HLA-B( *)4403 affected the plasticity of the allopeptide, revealing that molecular mimicry was associated with TCR specificity. Accordingly, molecular mimicry that is HLA and peptide dependent is a mechanism for human T cell alloreactivity between disparate cognate and allogeneic pHLA complexes.

Articles - 3kpm mentioned but not cited (2)

  1. Mechano-regulation of Peptide-MHC Class I Conformations Determines TCR Antigen Recognition. Wu P, Zhang T, Liu B, Fei P, Cui L, Qin R, Zhu H, Yao D, Martinez RJ, Hu W, An C, Zhang Y, Liu J, Shi J, Fan J, Yin W, Sun J, Zhou C, Zeng X, Xu C, Wang J, Evavold BD, Zhu C, Chen W, Lou J. Mol Cell 73 1015-1027.e7 (2019)
  2. Improved pan-specific MHC class I peptide-binding predictions using a novel representation of the MHC-binding cleft environment. Carrasco Pro S, Zimic M, Nielsen M. Tissue Antigens 83 94-100 (2014)


Reviews citing this publication (52)

  1. T cell antigen receptor recognition of antigen-presenting molecules. Rossjohn J, Gras S, Miles JJ, Turner SJ, Godfrey DI, McCluskey J. Annu Rev Immunol 33 169-200 (2015)
  2. Recognition of CD1d-restricted antigens by natural killer T cells. Rossjohn J, Pellicci DG, Patel O, Gapin L, Godfrey DI. Nat Rev Immunol 12 845-857 (2012)
  3. Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response. White KD, Chung WH, Hung SI, Mallal S, Phillips EJ. J Allergy Clin Immunol 136 219-34; quiz 235 (2015)
  4. Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex. Bharadwaj M, Illing P, Theodossis A, Purcell AW, Rossjohn J, McCluskey J. Annu Rev Pharmacol Toxicol 52 401-431 (2012)
  5. The importance of non-HLA antibodies in transplantation. Zhang Q, Reed EF. Nat Rev Nephrol 12 484-495 (2016)
  6. Understanding the drivers of MHC restriction of T cell receptors. La Gruta NL, Gras S, Daley SR, Thomas PG, Rossjohn J. Nat Rev Immunol 18 467-478 (2018)
  7. Structural and biophysical determinants of αβ T-cell antigen recognition. Bridgeman JS, Sewell AK, Miles JJ, Price DA, Cole DK. Immunology 135 9-18 (2012)
  8. A structural voyage toward an understanding of the MHC-I-restricted immune response: lessons learned and much to be learned. Gras S, Burrows SR, Turner SJ, Sewell AK, McCluskey J, Rossjohn J. Immunol Rev 250 61-81 (2012)
  9. Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options. Zumla A, Memish ZA, Maeurer M, Bates M, Mwaba P, Al-Tawfiq JA, Denning DW, Hayden FG, Hui DS. Lancet Infect Dis 14 1136-1149 (2014)
  10. Cross-reactivity of T cells and its role in the immune system. Petrova G, Ferrante A, Gorski J. Crit Rev Immunol 32 349-372 (2012)
  11. Role of Memory T Cells in Allograft Rejection and Tolerance. Benichou G, Gonzalez B, Marino J, Ayasoufi K, Valujskikh A. Front Immunol 8 170 (2017)
  12. Human leukocyte antigen-associated drug hypersensitivity. Illing PT, Vivian JP, Purcell AW, Rossjohn J, McCluskey J. Curr Opin Immunol 25 81-89 (2013)
  13. Paradoxical aspects of rapamycin immunobiology in transplantation. Ferrer IR, Araki K, Ford ML. Am J Transplant 11 654-659 (2011)
  14. Alloreactivity from human viral specific memory T-cells. D'Orsogna LJ, Roelen DL, Doxiadis II, Claas FH. Transpl Immunol 23 149-155 (2010)
  15. TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition. D'Orsogna LJ, Roelen DL, Doxiadis II, Claas FH. Immunogenetics 64 77-85 (2012)
  16. Overcoming the memory barrier in tolerance induction: molecular mimicry and functional heterogeneity among pathogen-specific T-cell populations. Ford ML, Larsen CP. Curr Opin Organ Transplant 15 405-410 (2010)
  17. Emerging Concepts in TCR Specificity: Rationalizing and (Maybe) Predicting Outcomes. Singh NK, Riley TP, Baker SCB, Borrman T, Weng Z, Baker BM. J Immunol 199 2203-2213 (2017)
  18. The structural bases of direct T-cell allorecognition: implications for T-cell-mediated transplant rejection. Gras S, Kjer-Nielsen L, Chen Z, Rossjohn J, McCluskey J. Immunol Cell Biol 89 388-395 (2011)
  19. The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions. Illing PT, Purcell AW, McCluskey J. Immunogenetics 69 617-630 (2017)
  20. The primacy of gastrointestinal tract antigen-presenting cells in lethal graft-versus-host disease. Koyama M, Hill GR. Blood 134 2139-2148 (2019)
  21. Alloantigen presentation and graft-versus-host disease: fuel for the fire. Koyama M, Hill GR. Blood 127 2963-2970 (2016)
  22. Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms. D'Orsogna L, van den Heuvel H, van Kooten C, Heidt S, Claas FHJ. Immunogenetics 69 631-641 (2017)
  23. Predicting alloreactivity in transplantation. Geneugelijk K, Thus KA, Spierings E. J Immunol Res 2014 159479 (2014)
  24. Microbiota—implications for immunity and transplantation. Bromberg JS, Fricke WF, Brinkman CC, Simon T, Mongodin EF. Nat Rev Nephrol 11 342-353 (2015)
  25. TCR Recognition of Peptide-MHC-I: Rule Makers and Breakers. Szeto C, Lobos CA, Nguyen AT, Gras S. Int J Mol Sci 22 E68 (2020)
  26. Understanding the complexity and malleability of T-cell recognition. Miles JJ, McCluskey J, Rossjohn J, Gras S. Immunol Cell Biol 93 433-441 (2015)
  27. HLA and kidney disease: from associations to mechanisms. Robson KJ, Ooi JD, Holdsworth SR, Rossjohn J, Kitching AR. Nat Rev Nephrol 14 636-655 (2018)
  28. New Insights into Graft-Versus-Host Disease and Graft Rejection. Perkey E, Maillard I. Annu Rev Pathol 13 219-245 (2018)
  29. Diversity-oriented approaches for interrogating T-cell receptor repertoire, ligand recognition, and function. Birnbaum ME, Dong S, Garcia KC. Immunol Rev 250 82-101 (2012)
  30. Autoimmune aspects of psoriasis: Heritability and autoantigens. Prinz JC. Autoimmun Rev 16 970-979 (2017)
  31. Co-Stimulatory Blockade of the CD28/CD80-86/CTLA-4 Balance in Transplantation: Impact on Memory T Cells? Ville S, Poirier N, Blancho G, Vanhove B. Front Immunol 6 411 (2015)
  32. Advances in direct T-cell alloreactivity: function, avidity, biophysics and structure. Smith C, Miles JJ, Khanna R. Am J Transplant 12 15-26 (2012)
  33. Generation of MHC class II-peptide ligands for CD4 T-cell allorecognition of MHC class II molecules. Leddon SA, Sant AJ. Curr Opin Organ Transplant 15 505-511 (2010)
  34. The versatility of the αβ T-cell antigen receptor. Bhati M, Cole DK, McCluskey J, Sewell AK, Rossjohn J. Protein Sci 23 260-272 (2014)
  35. What Is Direct Allorecognition? Boardman DA, Jacob J, Smyth LA, Lombardi G, Lechler RI. Curr Transplant Rep 3 275-283 (2016)
  36. Minor histocompatibility antigens: presentation principles, recognition logic and the potential for a healing hand. Spencer CT, Gilchuk P, Dragovic SM, Joyce S. Curr Opin Organ Transplant 15 512-525 (2010)
  37. Predisposed αβ T cell antigen receptor recognition of MHC and MHC-I like molecules? Eckle SB, Turner SJ, Rossjohn J, McCluskey J. Curr Opin Immunol 25 653-659 (2013)
  38. Alloreactivity of virus-specific T cells: possible implication of graft-versus-host disease and graft-versus-leukemia effects. Fuji S, Kapp M, Einsele H. Front Immunol 4 330 (2013)
  39. Endogenous-peptide-dependent alloreactivity: new scientific insights and clinical implications. D'Orsogna LJ, Nguyen TH, Claas FH, Witt C, Mifsud NA. Tissue Antigens 81 399-407 (2013)
  40. The intersection of affinity and specificity in the development and optimization of T cell receptor based therapeutics. Riley TP, Baker BM. Semin Cell Dev Biol 84 30-41 (2018)
  41. Immunological Mechanisms of Metal Allergies and the Nickel-Specific TCR-pMHC Interface. Riedel F, Aparicio-Soto M, Curato C, Thierse HJ, Siewert K, Luch A. Int J Environ Res Public Health 18 10867 (2021)
  42. Aspects of histocompatibility testing in xenotransplantation. Ladowski JM, Houp J, Hauptfeld-Dolejsek V, Javed M, Hara H, Cooper DKC. Transpl Immunol 67 101409 (2021)
  43. Specificity of Adaptive Immune Responses in Central Nervous System Health, Aging and Diseases. Rickenbach C, Gericke C. Front Neurosci 15 806260 (2021)
  44. Typical and atypical properties of peripheral nerve allografts enable novel strategies to repair segmental-loss injuries. Bittner GD, Bushman JS, Ghergherehchi CL, Roballo KCS, Shores JT, Smith TA. J Neuroinflammation 19 60 (2022)
  45. Botryllus schlosseri as a Unique Colonial Chordate Model for the Study and Modulation of Innate Immune Activity. Goldstein O, Mandujano-Tinoco EA, Levy T, Talice S, Raveh T, Gershoni-Yahalom O, Voskoboynik A, Rosental B. Mar Drugs 19 454 (2021)
  46. Lung Injury and Loss of Regulatory T Cells Primes for Lung-Restricted Autoimmunity. Akbarpour M, Bharat A. Crit Rev Immunol 37 23-37 (2017)
  47. A Review of Cyclophosphamide-Induced Transplantation Tolerance in Mice and Its Relationship With the HLA-Haploidentical Bone Marrow Transplantation/Post-Transplantation Cyclophosphamide Platform. Mayumi H. Front Immunol 12 744430 (2021)
  48. Analysis of T-Cell Receptor Repertoire in Transplantation: Fingerprint of T Cell-mediated Alloresponse. Tian G, Li M, Lv G. Front Immunol 12 778559 (2021)
  49. Heterologous Immunity of Virus-Specific T Cells Leading to Alloreactivity: Possible Implications for Solid Organ Transplantation. Karahan GE, Claas FHJ, Heidt S. Viruses 13 2359 (2021)
  50. Mouse Models of Antigen Presentation in Hematopoietic Stem Cell Transplantation. Koyama M, Hill GR. Front Immunol 12 715893 (2021)
  51. Innate Immunity Mechanisms in Marine Multicellular Organisms. Guryanova SV, Ovchinnikova TV. Mar Drugs 20 549 (2022)
  52. The good and the bad of T cell cross-reactivity: challenges and opportunities for novel therapeutics in autoimmunity and cancer. Gouttefangeas C, Klein R, Maia A. Front Immunol 14 1212546 (2023)

Articles citing this publication (120)

  1. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Illing PT, Vivian JP, Dudek NL, Kostenko L, Chen Z, Bharadwaj M, Miles JJ, Kjer-Nielsen L, Gras S, Williamson NA, Burrows SR, Purcell AW, Rossjohn J, McCluskey J. Nature 486 554-558 (2012)
  2. Deconstructing the peptide-MHC specificity of T cell recognition. Birnbaum ME, Mendoza JL, Sethi DK, Dong S, Glanville J, Dobbins J, Ozkan E, Davis MM, Wucherpfennig KW, Garcia KC. Cell 157 1073-1087 (2014)
  3. A single autoimmune T cell receptor recognizes more than a million different peptides. Wooldridge L, Ekeruche-Makinde J, van den Berg HA, Skowera A, Miles JJ, Tan MP, Dolton G, Clement M, Llewellyn-Lacey S, Price DA, Peakman M, Sewell AK. J Biol Chem 287 1168-1177 (2012)
  4. T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex. Adams JJ, Narayanan S, Liu B, Birnbaum ME, Kruse AC, Bowerman NA, Chen W, Levin AM, Connolly JM, Zhu C, Kranz DM, Garcia KC. Immunity 35 681-693 (2011)
  5. Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors. Pellicci DG, Clarke AJ, Patel O, Mallevaey T, Beddoe T, Le Nours J, Uldrich AP, McCluskey J, Besra GS, Porcelli SA, Gapin L, Godfrey DI, Rossjohn J. Nat Immunol 12 827-833 (2011)
  6. Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognition. Cole DK, Edwards ES, Wynn KK, Clement M, Miles JJ, Ladell K, Ekeruche J, Gostick E, Adams KJ, Skowera A, Peakman M, Wooldridge L, Price DA, Sewell AK. J Immunol 185 2600-2610 (2010)
  7. Cutting edge: Rapamycin augments pathogen-specific but not graft-reactive CD8+ T cell responses. Ferrer IR, Wagener ME, Robertson JM, Turner AP, Araki K, Ahmed R, Kirk AD, Larsen CP, Ford ML. J Immunol 185 2004-2008 (2010)
  8. Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity. Cole DK, Bulek AM, Dolton G, Schauenberg AJ, Szomolay B, Rittase W, Trimby A, Jothikumar P, Fuller A, Skowera A, Rossjohn J, Zhu C, Miles JJ, Peakman M, Wooldridge L, Rizkallah PJ, Sewell AK. J Clin Invest 126 2191-2204 (2016)
  9. Molecular architecture of the αβ T cell receptor-CD3 complex. Birnbaum ME, Berry R, Hsiao YS, Chen Z, Shingu-Vazquez MA, Yu X, Waghray D, Fischer S, McCluskey J, Rossjohn J, Walz T, Garcia KC. Proc Natl Acad Sci U S A 111 17576-17581 (2014)
  10. Molecular basis for universal HLA-A*0201-restricted CD8+ T-cell immunity against influenza viruses. Valkenburg SA, Josephs TM, Clemens EB, Grant EJ, Nguyen TH, Wang GC, Price DA, Miller A, Tong SY, Thomas PG, Doherty PC, Rossjohn J, Gras S, Kedzierska K. Proc Natl Acad Sci U S A 113 4440-4445 (2016)
  11. Peptide length determines the outcome of TCR/peptide-MHCI engagement. Ekeruche-Makinde J, Miles JJ, van den Berg HA, Skowera A, Cole DK, Dolton G, Schauenburg AJ, Tan MP, Pentier JM, Llewellyn-Lacey S, Miles KM, Bulek AM, Clement M, Williams T, Trimby A, Bailey M, Rizkallah P, Rossjohn J, Peakman M, Price DA, Burrows SR, Sewell AK, Wooldridge L. Blood 121 1112-1123 (2013)
  12. A single T cell receptor bound to major histocompatibility complex class I and class II glycoproteins reveals switchable TCR conformers. Yin L, Huseby E, Scott-Browne J, Rubtsova K, Pinilla C, Crawford F, Marrack P, Dai S, Kappler JW. Immunity 35 23-33 (2011)
  13. Evolving concepts of specificity in immune reactions. Eisen HN, Chakraborty AK. Proc Natl Acad Sci U S A 107 22373-22380 (2010)
  14. Human T cell receptor occurrence patterns encode immune history, genetic background, and receptor specificity. DeWitt WS, Smith A, Schoch G, Hansen JA, Matsen FA, Bradley P. Elife 7 e38358 (2018)
  15. Abacavir-reactive memory T cells are present in drug naïve individuals. Lucas A, Lucas M, Strhyn A, Keane NM, McKinnon E, Pavlos R, Moran EM, Meyer-Pannwitt V, Gaudieri S, D'Orsogna L, Kalams S, Ostrov DA, Buus S, Peters B, Mallal S, Phillips E. PLoS One 10 e0117160 (2015)
  16. Conformational melding permits a conserved binding geometry in TCR recognition of foreign and self molecular mimics. Borbulevych OY, Piepenbrink KH, Baker BM. J Immunol 186 2950-2958 (2011)
  17. The multiple mechanisms of T cell receptor cross-reactivity. Yin Y, Mariuzza RA. Immunity 31 849-851 (2009)
  18. Tapasin dependence of major histocompatibility complex class I molecules correlates with their conformational flexibility. Garstka MA, Fritzsche S, Lenart I, Hein Z, Jankevicius G, Boyle LH, Elliott T, Trowsdale J, Antoniou AN, Zacharias M, Springer S. FASEB J 25 3989-3998 (2011)
  19. Degenerate T-cell recognition of peptides on MHC molecules creates large holes in the T-cell repertoire. Calis JJ, de Boer RJ, Keşmir C. PLoS Comput Biol 8 e1002412 (2012)
  20. Congress Survey of the 2009 commercial optical biosensor literature. Rich RL, Myszka DG. J Mol Recognit 24 892-914 (2011)
  21. Evolutionarily conserved features contribute to αβ T cell receptor specificity. Scott-Browne JP, Crawford F, Young MH, Kappler JW, Marrack P, Gapin L. Immunity 35 526-535 (2011)
  22. Structural basis of specificity and cross-reactivity in T cell receptors specific for cytochrome c-I-E(k). Newell EW, Ely LK, Kruse AC, Reay PA, Rodriguez SN, Lin AE, Kuhns MS, Garcia KC, Davis MM. J Immunol 186 5823-5832 (2011)
  23. Origin and biology of the allogeneic response. Lakkis FG, Lechler RI. Cold Spring Harb Perspect Med 3 a014993 (2013)
  24. A structural basis for varied αβ TCR usage against an immunodominant EBV antigen restricted to a HLA-B8 molecule. Gras S, Wilmann PG, Chen Z, Halim H, Liu YC, Kjer-Nielsen L, Purcell AW, Burrows SR, McCluskey J, Rossjohn J. J Immunol 188 311-321 (2012)
  25. T cell receptor cross-reactivity expanded by dramatic peptide-MHC adaptability. Riley TP, Hellman LM, Gee MH, Mendoza JL, Alonso JA, Foley KC, Nishimura MI, Vander Kooi CW, Garcia KC, Baker BM. Nat Chem Biol 14 934-942 (2018)
  26. T-cell receptor (TCR)-peptide specificity overrides affinity-enhancing TCR-major histocompatibility complex interactions. Cole DK, Miles KM, Madura F, Holland CJ, Schauenburg AJ, Godkin AJ, Bulek AM, Fuller A, Akpovwa HJ, Pymm PG, Liddy N, Sami M, Li Y, Rizkallah PJ, Jakobsen BK, Sewell AK. J Biol Chem 289 628-638 (2014)
  27. How structural adaptability exists alongside HLA-A2 bias in the human αβ TCR repertoire. Blevins SJ, Pierce BG, Singh NK, Riley TP, Wang Y, Spear TT, Nishimura MI, Weng Z, Baker BM. Proc Natl Acad Sci U S A 113 E1276-85 (2016)
  28. Molecular mimicry: its evolution from concept to mechanism as a cause of autoimmune diseases. Oldstone MB. Monoclon Antib Immunodiagn Immunother 33 158-165 (2014)
  29. Broad CD8+ T cell cross-recognition of distinct influenza A strains in humans. Grant EJ, Josephs TM, Loh L, Clemens EB, Sant S, Bharadwaj M, Chen W, Rossjohn J, Gras S, Kedzierska K. Nat Commun 9 5427 (2018)
  30. A structural basis for antigen presentation by the MHC class Ib molecule, Qa-1b. Zeng L, Sullivan LC, Vivian JP, Walpole NG, Harpur CM, Rossjohn J, Clements CS, Brooks AG. J Immunol 188 302-310 (2012)
  31. How an alloreactive T-cell receptor achieves peptide and MHC specificity. Wang Y, Singh NK, Spear TT, Hellman LM, Piepenbrink KH, McMahan RH, Rosen HR, Vander Kooi CW, Nishimura MI, Baker BM. Proc Natl Acad Sci U S A 114 E4792-E4801 (2017)
  32. Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitope. Chen AT, Cornberg M, Gras S, Guillonneau C, Rossjohn J, Trees A, Emonet S, de la Torre JC, Welsh RM, Selin LK. PLoS Pathog 8 e1002633 (2012)
  33. Tissue specificity of cross-reactive allogeneic responses by EBV EBNA3A-specific memory T cells. D'Orsogna LJ, Roelen DL, van der Meer-Prins EM, van der Pol P, Franke-van Dijk ME, Eikmans M, Anholts J, Rossjohn J, McCluskey J, Mulder A, van Kooten C, Doxiadis II, Claas FH. Transplantation 91 494-500 (2011)
  34. Virus-Specific CD8(+) T Cells Cross-Reactive to Donor-Alloantigen Are Transiently Present in the Circulation of Kidney Transplant Recipients Infected With CMV and/or EBV. Heutinck KM, Yong SL, Tonneijck L, van den Heuvel H, van der Weerd NC, van der Pant KA, Bemelman FJ, Claas FH, Ten Berge IJ. Am J Transplant 16 1480-1491 (2016)
  35. Augmentation of Recipient Adaptive Alloimmunity by Donor Passenger Lymphocytes within the Transplant. Harper IG, Ali JM, Harper SJ, Wlodek E, Alsughayyir J, Negus MC, Qureshi MS, Motalleb-Zadeh R, Saeb-Parsy K, Bolton EM, Bradley JA, Clatworthy MR, Conlon TM, Pettigrew GJ. Cell Rep 15 1214-1227 (2016)
  36. Highly divergent T-cell receptor binding modes underlie specific recognition of a bulged viral peptide bound to a human leukocyte antigen class I molecule. Liu YC, Miles JJ, Neller MA, Gostick E, Price DA, Purcell AW, McCluskey J, Burrows SR, Rossjohn J, Gras S. J Biol Chem 288 15442-15454 (2013)
  37. A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity. Ooi JD, Jiang JH, Eggenhuizen PJ, Chua LL, van Timmeren M, Loh KL, O'Sullivan KM, Gan PY, Zhong Y, Tsyganov K, Shochet LR, Ryan J, Stegeman CA, Fugger L, Reid HH, Rossjohn J, Heeringa P, Holdsworth SR, Peleg AY, Kitching AR. Nat Commun 10 3392 (2019)
  38. Crossreactivity of a human autoimmune TCR is dominated by a single TCR loop. Sethi DK, Gordo S, Schubert DA, Wucherpfennig KW. Nat Commun 4 2623 (2013)
  39. Low-Affinity Memory CD8+ T Cells Mediate Robust Heterologous Immunity. Krummey SM, Martinez RJ, Andargachew R, Liu D, Wagener M, Kohlmeier JE, Evavold BD, Larsen CP, Ford ML. J Immunol 196 2838-2846 (2016)
  40. Alloreactivity is limited by the endogenous peptide repertoire. Morris GP, Ni PP, Allen PM. Proc Natl Acad Sci U S A 108 3695-3700 (2011)
  41. Quantitative and functional diversity of cross-reactive EBV-specific CD8+ T cells in a longitudinal study cohort of lung transplant recipients. Mifsud NA, Nguyen TH, Tait BD, Kotsimbos TC. Transplantation 90 1439-1449 (2010)
  42. The energetic basis underpinning T-cell receptor recognition of a super-bulged peptide bound to a major histocompatibility complex class I molecule. Liu YC, Chen Z, Burrows SR, Purcell AW, McCluskey J, Rossjohn J, Gras S. J Biol Chem 287 12267-12276 (2012)
  43. CD8+ TCR repertoire formation is guided primarily by the peptide component of the antigenic complex. Koning D, Costa AI, Hoof I, Miles JJ, Nanlohy NM, Ladell K, Matthews KK, Venturi V, Schellens IM, Borghans JA, Kesmir C, Price DA, van Baarle D. J Immunol 190 931-939 (2013)
  44. Heterogeneity within T Cell Memory: Implications for Transplant Tolerance. Krummey SM, Ford ML. Front Immunol 3 36 (2012)
  45. Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronaviruses. Tan CCS, Owen CJ, Tham CYL, Bertoletti A, van Dorp L, Balloux F. Infect Genet Evol 95 105075 (2021)
  46. Previously Hidden Dynamics at the TCR-Peptide-MHC Interface Revealed. Fodor J, Riley BT, Borg NA, Buckle AM. J Immunol 200 4134-4145 (2018)
  47. TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide-HLA Complex. Coles CH, Mulvaney RM, Malla S, Walker A, Smith KJ, Lloyd A, Lowe KL, McCully ML, Martinez Hague R, Aleksic M, Harper J, Paston SJ, Donnellan Z, Chester F, Wiederhold K, Robinson RA, Knox A, Stacey AR, Dukes J, Baston E, Griffin S, Jakobsen BK, Vuidepot A, Harper S. J Immunol 204 1943-1953 (2020)
  48. Vaccine-induced allo-HLA-reactive memory T cells in a kidney transplantation candidate. D'Orsogna LJ, van Besouw NM, van der Meer-Prins EM, van der Pol P, Franke-van Dijk M, Zoet YM, van der Slik A, Weimar W, van Kooten C, Mulder A, Roelen DL, Doxiadis II, Claas FH. Transplantation 91 645-651 (2011)
  49. Minimal conformational plasticity enables TCR cross-reactivity to different MHC class II heterodimers. Holland CJ, Rizkallah PJ, Vollers S, Calvo-Calle JM, Madura F, Fuller A, Sewell AK, Stern LJ, Godkin A, Cole DK. Sci Rep 2 629 (2012)
  50. Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy. Ochi T, Nakatsugawa M, Chamoto K, Tanaka S, Yamashita Y, Guo T, Fujiwara H, Yasukawa M, Butler MO, Hirano N. Cancer Immunol Res 3 1070-1081 (2015)
  51. Structural basis of cross-allele presentation by HLA-A*0301 and HLA-A*1101 revealed by two HIV-derived peptide complexes. Zhang S, Liu J, Cheng H, Tan S, Qi J, Yan J, Gao GF. Mol Immunol 49 395-401 (2011)
  52. Improving antigenic peptide vaccines for cancer immunotherapy using a dominant tumor-specific T cell receptor. Buhrman JD, Jordan KR, Munson DJ, Moore BL, Kappler JW, Slansky JE. J Biol Chem 288 33213-33225 (2013)
  53. Soluble T-cell receptors produced in human cells for targeted delivery. Walseng E, Wälchli S, Fallang LE, Yang W, Vefferstad A, Areffard A, Olweus J. PLoS One 10 e0119559 (2015)
  54. Disparate epitopes mediating protective heterologous immunity to unrelated viruses share peptide-MHC structural features recognized by cross-reactive T cells. Shen ZT, Nguyen TT, Daniels KA, Welsh RM, Stern LJ. J Immunol 191 5139-5152 (2013)
  55. Lack of Heterologous Cross-reactivity toward HLA-A*02:01 Restricted Viral Epitopes Is Underpinned by Distinct αβT Cell Receptor Signatures. Grant EJ, Josephs TM, Valkenburg SA, Wooldridge L, Hellard M, Rossjohn J, Bharadwaj M, Kedzierska K, Gras S. J Biol Chem 291 24335-24351 (2016)
  56. The ability to rearrange dual TCRs enhances positive selection, leading to increased Allo- and Autoreactive T cell repertoires. Ni PP, Solomon B, Hsieh CS, Allen PM, Morris GP. J Immunol 193 1778-1786 (2014)
  57. Allo-HLA Cross-Reactivities of Cytomegalovirus-, Influenza-, and Varicella Zoster Virus-Specific Memory T Cells Are Shared by Different Healthy Individuals. van den Heuvel H, Heutinck KM, van der Meer-Prins EMW, Yong SL, van Miert PPMC, Anholts JDH, Franke-van Dijk MEI, Zhang XQ, Roelen DL, Ten Berge RJM, Claas FHJ. Am J Transplant 17 2033-2044 (2017)
  58. Differential utilization of binding loop flexibility in T cell receptor ligand selection and cross-reactivity. Ayres CM, Scott DR, Corcelli SA, Baker BM. Sci Rep 6 25070 (2016)
  59. A molecular basis for the interplay between T cells, viral mutants, and human leukocyte antigen micropolymorphism. Liu YC, Chen Z, Neller MA, Miles JJ, Purcell AW, McCluskey J, Burrows SR, Rossjohn J, Gras S. J Biol Chem 289 16688-16698 (2014)
  60. HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome. Illing PT, Pymm P, Croft NP, Hilton HG, Jojic V, Han AS, Mendoza JL, Mifsud NA, Dudek NL, McCluskey J, Parham P, Rossjohn J, Vivian JP, Purcell AW. Nat Commun 9 4693 (2018)
  61. Molecular imprint of exposure to naturally occurring genetic variants of human cytomegalovirus on the T cell repertoire. Smith C, Gras S, Brennan RM, Bird NL, Valkenburg SA, Twist KA, Burrows JM, Miles JJ, Chambers D, Bell S, Campbell S, Kedzierska K, Burrows SR, Rossjohn J, Khanna R. Sci Rep 4 3993 (2014)
  62. The complex and specific pMHC interactions with diverse HIV-1 TCR clonotypes reveal a structural basis for alterations in CTL function. Xia Z, Chen H, Kang SG, Huynh T, Fang JW, Lamothe PA, Walker BD, Zhou R. Sci Rep 4 4087 (2014)
  63. The effect of mutations on the alloreactive T cell receptor/peptide-MHC interface structure: a molecular dynamics study. Wolfson MY, Nam K, Chakraborty AK. J Phys Chem B 115 8317-8327 (2011)
  64. The molecular basis of how buried human leukocyte antigen polymorphism modulates natural killer cell function. Saunders PM, MacLachlan BJ, Pymm P, Illing PT, Deng Y, Wong SC, Oates CVL, Purcell AW, Rossjohn J, Vivian JP, Brooks AG. Proc Natl Acad Sci U S A 117 11636-11647 (2020)
  65. T Cell Cross-Reactivity between a Highly Immunogenic EBV Epitope and a Self-Peptide Naturally Presented by HLA-B*18:01+ Cells. Rist MJ, Hibbert KM, Croft NP, Smith C, Neller MA, Burrows JM, Miles JJ, Purcell AW, Rossjohn J, Gras S, Burrows SR. J Immunol 194 4668-4675 (2015)
  66. Viral infection causes a shift in the self peptide repertoire presented by human MHC class I molecules. Spencer CT, Bezbradica JS, Ramos MG, Arico CD, Conant SB, Gilchuk P, Gray JJ, Zheng M, Niu X, Hildebrand W, Link AJ, Joyce S. Proteomics Clin Appl 9 1035-1052 (2015)
  67. Dynamical footprint of cross-reactivity in a human autoimmune T-cell receptor. Kumar A, Delogu F. Sci Rep 7 42496 (2017)
  68. Immune parameters to consider when choosing T-cell receptors for therapy. Burrows SR, Miles JJ. Front Immunol 4 229 (2013)
  69. Age-specific risk of renal graft loss from late acute rejection or non-compliance in the adolescent and young adult period. Ritchie AG, Clayton PA, McDonald SP, Kennedy SE. Nephrology (Carlton) 23 585-591 (2018)
  70. Cross-reactive anti-viral T cells increase prior to an episode of viral reactivation post human lung transplantation. Nguyen TH, Westall GP, Bull TE, Meehan AC, Mifsud NA, Kotsimbos TC. PLoS One 8 e56042 (2013)
  71. Unexpected T-cell recognition of an altered peptide ligand is driven by reversed thermodynamics. Allerbring EB, Duru AD, Uchtenhagen H, Madhurantakam C, Tomek MB, Grimm S, Mazumdar PA, Friemann R, Uhlin M, Sandalova T, Nygren PÅ, Achour A. Eur J Immunol 42 2990-3000 (2012)
  72. Crystal structures of HLA-A*0201 complexed with Melan-A/MART-1(26(27L)-35) peptidomimetics reveal conformational heterogeneity and highlight degeneracy of T cell recognition. Douat-Casassus C, Borbulevych O, Tarbe M, Gervois N, Jotereau F, Baker BM, Quideau S. J Med Chem 53 7061-7066 (2010)
  73. Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy. Bai P, Li Y, Zhou Q, Xia J, Wei PC, Deng H, Wu M, Chan SK, Kappler JW, Zhou Y, Tran E, Marrack P, Yin L. Oncoimmunology 10 1868130 (2021)
  74. Single-molecule motions of MHC class II rely on bound peptides. Kozono H, Matsushita Y, Ogawa N, Kozono Y, Miyabe T, Sekiguchi H, Ichiyanagi K, Okimoto N, Taiji M, Kanagawa O, Sasaki YC. Biophys J 108 350-359 (2015)
  75. Structural and energetic evidence for highly peptide-specific tumor antigen targeting via allo-MHC restriction. Simpson AA, Mohammed F, Salim M, Tranter A, Rickinson AB, Stauss HJ, Moss PA, Steven NM, Willcox BE. Proc Natl Acad Sci U S A 108 21176-21181 (2011)
  76. Structural and functional correlates of enhanced antiviral immunity generated by heteroclitic CD8 T cell epitopes. Trujillo JA, Gras S, Twist KA, Croft NP, Channappanavar R, Rossjohn J, Purcell AW, Perlman S. J Immunol 192 5245-5256 (2014)
  77. Structure and Function of HLA-A*02-Restricted Hantaan Virus Cytotoxic T-Cell Epitope That Mediates Effective Protective Responses in HLA-A2.1/K(b) Transgenic Mice. Ma Y, Cheng L, Yuan B, Zhang Y, Zhang C, Zhang Y, Tang K, Zhuang R, Chen L, Yang K, Zhang F, Jin B. Front Immunol 7 298 (2016)
  78. The early proximal αβ TCR signalosome specifies thymic selection outcome through a quantitative protein interaction network. Neier SC, Ferrer A, Wilton KM, Smith SEP, Kelcher AMH, Pavelko KD, Canfield JM, Davis TR, Stiles RJ, Chen Z, McCluskey J, Burrows SR, Rossjohn J, Hebrink DM, Carmona EM, Limper AH, Kappes DJ, Wettstein PJ, Johnson AJ, Pease LR, Daniels MA, Neuhauser C, Gil D, Schrum AG. Sci Immunol 4 eaal2201 (2019)
  79. Bi-specific MHC heterodimers for characterization of cross-reactive T cells. Shen ZT, Brehm MA, Daniels KA, Sigalov AB, Selin LK, Welsh RM, Stern LJ. J Biol Chem 285 33144-33153 (2010)
  80. DynaDom: structure-based prediction of T cell receptor inter-domain and T cell receptor-peptide-MHC (class I) association angles. Hoffmann T, Marion A, Antes I. BMC Struct Biol 17 2 (2017)
  81. Inability To Detect Cross-Reactive Memory T Cells Challenges the Frequency of Heterologous Immunity among Common Viruses. Rowntree LC, Nguyen THO, Halim H, Purcell AW, Rossjohn J, Gras S, Kotsimbos TC, Mifsud NA. J Immunol 200 3993-4003 (2018)
  82. Individual MHCI-Restricted T-Cell Receptors are Characterized by a Unique Peptide Recognition Signature. Wooldridge L. Front Immunol 4 199 (2013)
  83. Residue 81 confers a restricted C-terminal peptide binding motif in HLA-B*44:09. Huyton T, Schumacher H, Blasczyk R, Bade-Doeding C. Immunogenetics 64 663-668 (2012)
  84. Editorial Screening of viral specific T-cell lines for HLA alloreactivity prior to adoptive immunotherapy may prevent GvHD. D'Orsogna LJ, Roelen DL, Doxiadis II, Claas FH. Transpl Immunol 24 141 (2011)
  85. Comment Virally-Induced Heterologous Immunity in Renal Transplant Recipients: Important or Inconsequential? Ford ML. Am J Transplant 16 1348-1349 (2016)
  86. B*39:60, a novel HLA-B*39 allele identified by sequence-based typing. Ko SY, Oh HB, Heo YS, Jun JH, Kwon OJ. Tissue Antigens 77 155-156 (2011)
  87. Finding semirigid domains in biomolecules by clustering pair-distance variations. Kenn M, Ribarics R, Ilieva N, Schreiner W. Biomed Res Int 2014 731325 (2014)
  88. HLA Amino Acid Polymorphisms and Kidney Allograft Survival. Kamoun M, McCullough KP, Maiers M, Fernandez Vina MA, Li H, Teal V, Leichtman AB, Merion RM. Transplantation 101 e170-e177 (2017)
  89. High-throughput modeling and scoring of TCR-pMHC complexes to predict cross-reactive peptides. Borrman T, Pierce BG, Vreven T, Baker BM, Weng Z. Bioinformatics 36 5377-5385 (2021)
  90. Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor. Rühl G, Niedl AG, Patronov A, Siewert K, Pinkert S, Kalemanov M, Friese MA, Attfield KE, Antes I, Hohlfeld R, Dornmair K. Neurol Neuroimmunol Neuroinflamm 3 e241 (2016)
  91. Regeneration of Tumor-Antigen-Specific Cytotoxic T Lymphocytes from iPSCs Transduced with Exogenous TCR Genes. Maeda T, Nagano S, Kashima S, Terada K, Agata Y, Ichise H, Ohtaka M, Nakanishi M, Fujiki F, Sugiyama H, Kitawaki T, Kadowaki N, Takaori-Kondo A, Masuda K, Kawamoto H. Mol Ther Methods Clin Dev 19 250-260 (2020)
  92. Stimulation of HIV-specific T cell clonotypes using allogeneic HLA. Almeida CA, van Miert P, O'Driscoll K, Zoet YM, Chopra A, Watson M, de Santis D, Witt C, John M, Claas FHJ, D'Orsogna LJ. Cell Immunol 316 32-40 (2017)
  93. Tacrolimus treatment for infertility related to maternal-fetal immune interactions. Yamaguchi K. Am J Reprod Immunol 81 e13097 (2019)
  94. Understanding TR binding to pMHC complexes: how does a TR scan many pMHC complexes yet preferentially bind to one. Khan JM, Ranganathan S. PLoS One 6 e17194 (2011)
  95. Preferential HLA-B27 Allorecognition Displayed by Multiple Cross-Reactive Antiviral CD8+ T Cell Receptors. Rowntree LC, van den Heuvel H, Sun J, D'Orsogna LJ, Nguyen THO, Claas FHJ, Rossjohn J, Kotsimbos TC, Purcell AW, Mifsud NA. Front Immunol 11 248 (2020)
  96. Simultaneous Recognition of Allogeneic MHC and Cognate Autoantigen by Autoreactive T Cells in Transplant Rejection. Burrack AL, Landry LG, Siebert J, Coulombe M, Gill RG, Nakayama M. J Immunol 200 1504-1512 (2018)
  97. Donor-specific alloreactive T cells can be quantified from whole blood, and may predict cellular rejection after renal transplantation. Fischer M, Leyking S, Schäfer M, Elsäßer J, Janssen M, Mihm J, van Bentum K, Fliser D, Sester M, Sester U. Eur J Immunol 47 1220-1231 (2017)
  98. Geometry Dynamics of α -Helices in Different Class I Major Histocompatibility Complexes. Ribarics R, Kenn M, Karch R, Ilieva N, Schreiner W. J Immunol Res 2015 173593 (2015)
  99. Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses. Chan KL, Gomez J, Cardinez C, Kumari N, Sparbier CE, Lam EYN, Yeung MM, Garciaz S, Kuzich JA, Ong DM, Brown FC, Chan YC, Vassiliadis D, Wainwright EN, Motazedian A, Gillespie A, Fennell KA, Lai J, House IG, Macpherson L, Ang CS, Dawson SJ, Beavis PA, Wei AH, Burr ML, Dawson MA. Cancer Cell 40 1190-1206.e9 (2022)
  100. SHP-1 Acts as a Key Regulator of Alloresponses by Modulating LFA-1-Mediated Adhesion in Primary Murine T Cells. Sauer MG, Herbst J, Diekmann U, Rudd CE, Kardinal C. Mol Cell Biol 36 3113-3127 (2016)
  101. A Novel Approach of Identifying Immunodominant Self and Viral Antigen Cross-Reactive T Cells and Defining the Epitopes They Recognize. Yang J, Jing L, James EA, Gebe JA, Koelle DM, Kwok WW. Front Immunol 9 2811 (2018)
  102. Detection of Virus-Specific CD8+ T Cells With Cross-Reactivity Against Alloantigens: Potency and Flaws of Present Experimental Methods. van den Heuvel H, Heutinck KM, van der Meer-Prins EP, Yong SL, Claas FH, Ten Berge IJ. Transplant Direct 1 e40 (2015)
  103. Dynamic characterization of HLA-B*44 Alleles: A comparative molecular dynamics simulation study. Ozbek P. Comput Biol Chem 62 12-16 (2016)
  104. Genetic Bias, Diversity Indices, Physiochemical Properties and CDR3 Motifs Divide Auto-Reactive from Allo-Reactive T-Cell Repertoires. Haigh OL, Grant EJ, Nguyen THO, Kedzierska K, Field MA, Miles JJ. Int J Mol Sci 22 1625 (2021)
  105. Geometric analysis of alloreactive HLA α-helices. Ribarics R, Karch R, Ilieva N, Schreiner W. Biomed Res Int 2014 943186 (2014)
  106. Peptidomes and Structures Illustrate Two Distinguishing Mechanisms of Alternating the Peptide Plasticity Caused by Swine MHC Class I Micropolymorphism. Wei X, Wang S, Li Z, Li Z, Qu Z, Wang S, Zou B, Liang R, Xia C, Zhang N. Front Immunol 12 592447 (2021)
  107. Spatiotemporal multistage consensus clustering in molecular dynamics studies of large proteins. Kenn M, Ribarics R, Ilieva N, Cibena M, Karch R, Schreiner W. Mol Biosyst 12 1600-1614 (2016)
  108. T Cell Repertoire Maturation Induced by Persistent and Latent Viral Infection Is Insufficient to Induce Costimulation Blockade Resistant Organ Allograft Rejection in Mice. Espinosa JR, Mou D, Adams BW, DiBernardo LR, MacDonald AL, McRae M, Miller AN, Song M, Stempora LL, Wang J, Iwakoshi NN, Kirk AD. Front Immunol 9 1371 (2018)
  109. A "hotspot" for autoimmune T cells in type 1 diabetes. Stadinski BD, Obst R, Huseby ES. J Clin Invest 126 2040-2042 (2016)
  110. Abacavir inhibits but does not cause self-reactivity to HLA-B*57:01-restricted EBV specific T cell receptors. Sooda A, Rwandamuriye F, Wanjalla CN, Jing L, Koelle DM, Peters B, Leary S, Chopra A, Calderwood MA, Mallal SA, Pavlos R, Watson M, Phillips EJ, Redwood AJ. Commun Biol 5 133 (2022)
  111. Identification of a naturally processed HLA-Cw7-binding peptide that cross-reacts with HLA-A24-restricted ovarian cancer-specific CTLs. Yamada E, Demachi-Okamura A, Kondo S, Akatsuka Y, Suzuki S, Shibata K, Kikkawa F, Kuzushima K. Tissue Antigens 86 164-171 (2015)
  112. Intramolecular Domain Movements of Free and Bound pMHC and TCR Proteins: A Molecular Dynamics Simulation Study. Karch R, Stocsits C, Ilieva N, Schreiner W. Cells 8 E720 (2019)
  113. The role of self-peptides in direct T cell allorecognition. Abdelsamed HA, Lakkis FG. J Clin Invest 131 e154096 (2021)
  114. Clinical characteristics of COVID-19 patients in Xiaogan, China: comparison between recent imported cases and earlier local cases. Hu YL, Ding T. Am J Transl Res 13 11999-12005 (2021)
  115. Conformational flexibility of a free and TCR-bound pMHC-I protein investigated by long-term molecular dynamics simulations. Tomasiak L, Karch R, Schreiner W. BMC Immunol 23 36 (2022)
  116. Detection of constant domain of human T cell antigen receptor alpha-chain via novel monoclonal antibody 7F18. Reed BK, Lee KA, Bell MP, Gil D, Schrum AG. Monoclon Antib Immunodiagn Immunother 33 386-392 (2014)
  117. HLA amino acid Mismatch-Based risk stratification of kidney allograft failure using a novel Machine learning algorithm. Dasariraju S, Gragert L, Wager GL, McCullough K, Brown NK, Kamoun M, Urbanowicz RJ. J Biomed Inform 142 104374 (2023)
  118. Machine-Learning-Assisted Analysis of TCR Profiling Data Unveils Cross-Reactivity between SARS-CoV-2 and a Wide Spectrum of Pathogens and Other Diseases. Georgakilas GK, Galanopoulos AP, Tsinaris Z, Kyritsi M, Mouchtouri VA, Speletas M, Hadjichristodoulou C. Biology (Basel) 11 1531 (2022)
  119. Sequence similarity between SARS-CoV-2 nucleocapsid and multiple sclerosis-associated proteins provides insight into viral neuropathogenesis following infection. Lake CM, Breen JJ. Sci Rep 13 389 (2023)
  120. TCR Sequencing in Mouse Models of Allorecognition Unveils the Features of Directly and Indirectly Activated Clonotypes. Tereshchenko V, Shevyrev D, Fisher M, Bulygin A, Khantakova J, Sennikov S. Int J Mol Sci 24 12075 (2023)


Quick links